Analysts at StockNews.com began coverage on shares of Ambev (NYSE:ABEV – Get Rating) in a research note issued on Thursday. The firm set a “buy” rating on the stock.
ABEV has been the subject of a number of other reports. UBS Group raised Ambev from a “sell” rating to a “buy” rating in a research note on Thursday, January 12th. TheStreet raised Ambev from a “c+” rating to a “b” rating in a research note on Friday, December 9th.
Ambev Stock Performance
NYSE:ABEV opened at $2.65 on Thursday. The company has a current ratio of 0.93, a quick ratio of 0.61 and a debt-to-equity ratio of 0.03. Ambev has a 12-month low of $2.40 and a 12-month high of $3.32. The stock has a 50-day moving average price of $2.59 and a 200 day moving average price of $2.80. The stock has a market capitalization of $41.70 billion, a P/E ratio of 14.72, a P/E/G ratio of 1.66 and a beta of 1.02.
Institutional Investors Weigh In On Ambev
Ambev Company Profile
Ambev SA engages in the production, distribution, and sale of beverages. Its products include beer, carbonated soft drinks, and other non-alcoholic and non-carbonated products. It operates through the following geographical segments: Brazil, and Central America and The Caribbean (CAC), and Canada. The Brazil segment focuses on the beer sales division and the NAB sales division.
Read More
- Get a free copy of the StockNews.com research report on Ambev (ABEV)
- Meta Platforms: Efficiency Gains Momentum, Stock Accelerates
- Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.